Company Earnings UpdateWalgreens Boots Alliance (NYSE: WBA) 3Q19 Results: Slow Performance at Boots UK, Company Reviewing Its US Store Estate Coresight Research July 1, 2019 Executive Summary Walgreens Boots Alliance reported marginal revenue growth of 0.7% in 3Q19, to $34.6 billion, in line with the consensus estimate. Diluted EPS came in at $1.13, down 16.3% year over year and below the consensus estimate of $1.19. Comps for the Retail Pharmacy USA business fell 1.1%, while Retail Pharmacy International comps decreased 6.8%. For FY19, Walgreens maintained guidance for roughly flat EPS at constant currency. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: US CPG Sales Tracker: CPG E-Commerce Spikes and Beauty Sales Growth Jumps, Driven by Prime Day and Competing July 2025 Sales EventsCEO Brief: Intelligent Inventory—Achieving Inventory Excellence3Q25 Retail Inventory Insights: Execution Discipline Drives Performance into Holiday 2025Economic and Financial Sentiment Stabilizes: Weekly US Consumer Sentiment, Week 14, 2025—Infographic
